LRRK2 and Parkinson disease: The proportion of positive αSyn SAA was lower in subgroups, including Leucine-rich repeat kinase 2 (LRRK2) PD at 67.5% positivity and participants with sporadic PD without olfactory deficit at 78.3% positivity [25].